FIELD: veterinary science; medicine.
SUBSTANCE: invention refers to medicine and veterinary science and can be used for prevention, treatment, prevention of recurrences of mastitis in animals, in particular cattle, goats, sheep, swine, dogs of large breeds. Method involves the oral administration of an agent based on the culture of the lactobacilli Fermentum CEPT 5716 strain. Agent is prescribed in a daily dosage of 3 to 12 billion units. Treatment is continued for at least 10 days until the target clinical values are achieved. Object of the invention is to develop a method of treating and preventing various forms and stages of mastitis in animals, which for a short period of time, with high effectiveness and safety provides the possibility of treating, reduces the use of antibiotics, as well as their ingestion into milk and milk products, provides prevention of antibiotic resistance and formation of insensitive strains in animal breeding and medicine, as well as increases milk yield and quality.
EFFECT: method provides reliable, painless, low-labor treatment of various forms and stages of mastitis, as well as increased milk yield.
7 cl, 1 dwg, 2 ex
Title | Year | Author | Number |
---|---|---|---|
MAMMAL MILK CELLS, COMPOSITIONS CONTAINING THEM, AND USING THEM FOR TREATING MASTITIS | 2008 |
|
RU2446814C2 |
STRAIN Lactobacillus fermentum HAVING BROAD SPECTRUM OF ANTAGONISTIC ACTIVITY AND PROBIOTIC LACTOBACTERIUM CONSORTIUM FOR MANUFACTURING BACTERIAL PREPARATIONS | 2013 |
|
RU2528862C1 |
INACTIVATED VACCINE AGAINST INFECTIOUS MASTITIS AND ENDOMETRITIS IN COWS, METHOD FOR ITS PRODUCTION | 2024 |
|
RU2840041C1 |
METABIOTIC COMPOSITION TO ENSURE COLONISATION RESISTANCE OF HUMAN INTESTINAL MICROBIOCENOSIS | 2015 |
|
RU2589818C1 |
STRAIN OF Lactobacillus fermentum Z, USED FOR PRODUCTION OF PROBIOTIC CULTURED MILK FOODS | 2008 |
|
RU2412239C2 |
METHOD FOR OBTAINING OF FERMENTED YOGURT-TYPE MILK PRODUCT | 2006 |
|
RU2307514C1 |
PHAGOBIOTIC - A COMBINED DRUG BASED ON BACTERIOPHAGES AND PROBIOTICS | 2023 |
|
RU2837170C1 |
USE OF A SYMBIOTIC CONSORTIUM OF PROBIOTIC LACTOBACILLI STRAINS ISOLATED FROM HUMAN MILK, WHICH HAS A BACTERICIDAL EFFECT ON MASTITIS-INDUCING PATHOGENS, FOR THE MANUFACTURE OF DRUGS FOR THE COMPLEX PREVENTION AND TREATMENT OF LACTATIONAL MASTITIS | 2022 |
|
RU2801119C1 |
SYNBIOTIC COMPOSITION FOR CORRECTION OF DYSBIOTIC GASTROINTESTINAL TRACT MICROBIOCENOSIS DISTURBANCES | 2015 |
|
RU2592988C1 |
COMPLEX PROBIOTIC PREPARATION FOR ANIMALS | 1997 |
|
RU2119796C1 |
Authors
Dates
2019-12-23—Published
2019-07-05—Filed